BlackRock tops 5% in Abivax, disclosure shows 5.14% stake
BlackRock crossed above the 5% threshold in Abivax on Sept. 25, reaching 5.14% of capital; voting rights rose to 5.07% (4,487,762 shares), with the move reflecting an increase in shares held as collateral.